Structural requirements for ErbB2 transactivation
- PMID: 11774204
Structural requirements for ErbB2 transactivation
Abstract
ErbB2 is a unique member of the ErbB family of receptor tyrosine kinases that is distinguished by the fact that no ligand has yet been identified. Due to the absence of an ErbB2 ligand, alternative mechanisms are used for ErbB2 activation. As such, when ErbB2 is overexpressed, kinase activation occurs in the absence of ligand because of constitutive homodimerization. However, at normal expression levels ErbB2 acts as the shared coreceptor for the ErbB family, and these heterodimeric complexes are activated in response to the partner ligand. While the extracellular domain and transmembrane domains are necessary for ErbB2 transactivation, the carboxy terminus is also required. Specifically, ligand-dependent ErbB2 transactivation requires a discrete three-amino-acid segment, located at the C-terminus of ErbB family members ErbB3, ErbB4, and the epidermal growth factor receptor. Transactivation of ErbB2 via the three-amino-acid segment likely represents a conserved mechanism for regulated signaling by the ErbB family of receptors.
Copyright 2001 by W.B. Saunders Company.
Similar articles
-
A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2.J Biol Chem. 1999 Jan 8;274(2):859-66. doi: 10.1074/jbc.274.2.859. J Biol Chem. 1999. PMID: 9873025
-
ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.Cell Signal. 2002 Sep;14(9):793-8. doi: 10.1016/s0898-6568(02)00019-0. Cell Signal. 2002. PMID: 12034361
-
The ErbB/HER family of protein-tyrosine kinases and cancer.Pharmacol Res. 2014 Jan;79:34-74. doi: 10.1016/j.phrs.2013.11.002. Epub 2013 Nov 20. Pharmacol Res. 2014. PMID: 24269963 Review.
-
Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.Cell Signal. 2007 Mar;19(3):466-71. doi: 10.1016/j.cellsig.2006.07.020. Epub 2006 Sep 15. Cell Signal. 2007. PMID: 16978839
-
ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium.J Mol Cell Cardiol. 2008 May;44(5):831-54. doi: 10.1016/j.yjmcc.2008.02.278. Epub 2008 Mar 4. J Mol Cell Cardiol. 2008. PMID: 18430438 Review.
Cited by
-
Sequence variants and haplotype analysis of cat ERBB2 gene: a survey on spontaneous cat mammary neoplastic and non-neoplastic lesions.Int J Mol Sci. 2012;13(3):2783-2800. doi: 10.3390/ijms13032783. Epub 2012 Mar 2. Int J Mol Sci. 2012. PMID: 22489125 Free PMC article.
-
Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.Clin Exp Metastasis. 2014 Mar;31(3):307-16. doi: 10.1007/s10585-013-9629-y. Epub 2013 Dec 15. Clin Exp Metastasis. 2014. PMID: 24338375
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous